No-Cost, No-Obligation Cincinnati Lipitor Diabetes Lawsuit Review

Bookmark and Share

Cincinnati Lipitor and Actos Lawsuits

Lipitor Diabetes Risk Information for Residents of Cincinnati

Cincinnati Lipitor Diabetes LawyersThe Lipitor diabetes risk has been documented in numerous reputable studies and analyses published in the United States and around the world in the past decade. Speculation on this topic was first backed by research in the 2008 study of another statin, Crestor, and then confirmed by a meta-analysis of clinical trials published in the British medical journal Lancet in 2010.

Early medical studies examining the Lipitor diabetes risk generally concluded that for many individuals, the risks associated with the drug were minor when compared to the drug’s benefits. The most recent studies on this matter, however, conclude that factors such as the type of statin prescribed, the dosage, and above all the patient’s demographic impact each patient’s relative risk for developing the disease. Most significantly, postmenopausal women have been found to face a 48% increase in risk for developing diabetes as a result of taking Lipitor and other statins.

Understanding Lipitor Diabetes

Multiple studies have shown that individuals taking statin drugs are more likely to develop Type II diabetes than individuals not taking statin drugs. Type II Diabetes is a metabolic disease characterized by high blood glucose. It is a chronic condition that worsens over time whereby the body becomes insulin-resistant and insulin-deficient. Long-term health risks of having persistently elevated blood sugar levels include kidney failure, stroke, heart attack and the need for amputation. Statin drugs are prescribed in order to reduce the risk of cardiovascular disease and stroke; developing diabetes puts patients at risk for these same serious health threats. In fact, adults who have diabetes are thought to be two to four times more likely to have heart disease or a stroke than adults who do not have the disease.

Medical Experts Warn of Lipitor Diabetes Risk for Elderly Women

lipitor diabetes riskIn the numerous studies that have been published examining the Lipitor diabetes connection, postmenopausal women have been shown to have the highest risk of developing Lipitor diabetes. Whereas the general public face a 9% increase in the risk of developing diabetes while taking statin drugs such as Lipitor, postmenopausal women face nearly a 50% increase in Lipitor diabetes risk. This finding was the result of a January 2012 Women’s Health Initiative (WHI) study published by the Archives of Internal Medicine which followed more than 150,000 women over the course of seven years. The study did not specify risk levels for different types of statins, but did conclude that women of all races experience a similarly high risk for developing type II diabetes when using statin drugs over a prolonged period of time.

Dr. Yunsheng Ma, a professor at the University of Massachusetts Medical School and one of the lead researchers for the WHI study said in an interview with, an independent cardiology news source, that the findings of this particular study had important implications for elderly women: “With this study, what we're seeing is that the risk of diabetes is particularly high in elderly women, and this risk is much larger than was observed in another previous meta-analysis. For doctors treating patients, we would like them to really look at the risk/benefit analysis, especially in different age groups, such as older women."

Until 2012, no conclusive research had been conducted on the effects of Lipitor on specific populations. This particular study confirmed adverse event reporting trends suggesting that elderly women face a much higher risk for diabetes from Lipitor than do other patients. Doctors do not yet understand why Lipitor increases blood sugar levels or causes diabetes.

In Light of Lipitor Diabetes Risk, Doctors Reconsider Drug's Safety

Co-author and lead researcher of the WHI study Dr. JoAnn Manson, of the Harvard Medical School and Brigham and Women’s Hospital in Boston, noted on that, “For those who advocate even more widespread use of statins -- virtually ‘putting statins in the water supply’ -- these findings give pause...” Many medical experts have expressed a similar sentiment, arguing that statins drugs such a Lipitor are over used and the risks of widespread use have not been carefully considered. In an interview with USA Today, Dr. Manson hoped her research would “help doctors understand why statins reduce the heart attack risk in people without pre-existing heart disease, but not the overall risk of death. Maybe that's because a statin's benefits for preventing heart attacks are canceled out by the increasing diabetes risk, Manson says.”

Cincinnati Lipitor Diabetes Lawyers Offer Assistance

Cincinnati Lipitor diabetes lawyers are experts in legal cases pertaining to patients who have developed diabetes while taking Lipitor or another statin drug. If you or a loved one fit that description, a Cincinnati Lipitor diabetes lawyer can answer your specific questions and tell you about your legal rights in Cincinnati.

Despite the clear risk of diabetes for women patients taking Lipitor, patients who are currently taking the drug are advised to continue to do so. However, Dr. Yunsheng Ma of the WHI study strongly urges physicians to make calculated decisions regarding the use of Lipitor, particularly for elderly women, and encourages the use of diet and lifestyle changes to reduce cholesterol in place of Lipitor whenever possible.

Lipitor Diabetes Lawsuits in Cincinnati

Persons who have developed diabetes while taking Lipitor may have grounds to file a Cincinnati Lipitor diabetes lawsuit. Cincinnati Lipitor diabetes lawsuits are represented on a contingency basis, meaning that you pay nothing if you do not receive compensation.

About Lipitor

Lipitor is the most popular drug in a class of medications known as statins. Statins are relied upon by over 20 million Americans to reduce the risk of heart disease and stroke from the buildup of bad cholesterol. By inhibiting the production of the enzyme HMG-CoA reductase, statins block the liver from producing low-density lipoprotein (LDL or “bad cholesterol). Lipitor is the statin drug sold by Pfizer that has been the most profitable prescription drug in American history, garnering cumulative sales of over $130 billion. Other statins include Pravachol, Zocor, Lescol, Mevacor, Altoprev, Livalo, Crestor, Advicor, Simcor, and Vytorin.